We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+12.25%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.91B
AUM Growth
+$100M
Cap. Flow
-$61.7M
Cap. Flow %
-3.22%
Top 10 Hldgs %
40.66%
Holding
350
New
52
Increased
58
Reduced
147
Closed
44

Top Buys

Rank Stock Value
1
LOW icon
Lowe's Companies
LOW
+$21.7M
2
ALL icon
Allstate
ALL
+$20.2M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$20.1M
4
SGI
Somnigroup International
SGI
+$19.4M
5
GNRC icon
Generac Holdings
GNRC
+$16.3M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$30.3M
2
CIEN icon
Ciena
CIEN
+$25.4M
3
EW icon
Edwards Lifesciences
EW
+$22M
4
BAX icon
Baxter International
BAX
+$20.9M
5
HII icon
Huntington Ingalls Industries
HII
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 36.47%
2 Consumer Discretionary 15.93%
3 Healthcare 15.71%
4 Communication Services 8.84%
5 Financials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BPMC
176
DELISTED
Blueprint Medicines
BPMC
$172K 0.01%
1,860
– –
LMNX
177
DELISTED
Luminex Corp
LMNX
$163K 0.01%
+6,210
New +$190K
RARE icon
178
Ultragenyx Pharmaceutical
RARE
$2.64B
$161K 0.01%
1,960
-10
-0.5% -$829
HSTM icon
179
HealthStream
HSTM
$859M
$160K 0.01%
7,960
-20
-0.3% -$425
EXLS icon
180
EXL Service
EXLS
$5.32B
$157K 0.01%
11,900
– –
NTRA icon
181
Natera
NTRA
$45.9B
$157K 0.01%
2,170
– –
KBH icon
182
KB Home
KBH
$3.47B
$151K 0.01%
+3,930
New +$137K
EBS icon
183
Emergent Biosolutions
EBS
$229M
$150K 0.01%
1,450
-310
-18% -$33.4K
AGNT
184
AGNT Inc
AGNT
$715M
$150K 0.01%
+7,440
New +$115K
FBM
185
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$146K 0.01%
9,300
– –
ARWR icon
186
Arrowhead Research
ARWR
$12.5B
$143K 0.01%
3,310
– –
FCN icon
187
FTI Consulting
FCN
$4.17B
$131K 0.01%
1,240
– –
INSM icon
188
Insmed
INSM
$29.4B
$130K 0.01%
4,030
+920
+30% +$26.4K
FOLD
189
DELISTED
Amicus Therapeutics
FOLD
$127K 0.01%
9,000
+820
+10% +$12K
BRK.B icon
190
Berkshire Hathaway Class B
BRK.B
$1.14T
$123K 0.01%
579
-10
-2% -$2.05K
HALO icon
191
Halozyme
HALO
$12.2B
$117K 0.01%
4,440
-850
-16% -$23.7K
SANM icon
192
Sanmina
SANM
$10.7B
$117K 0.01%
4,340
-10
-0.2% -$272
BBIO icon
193
BridgeBio Pharma
BBIO
$16.6B
$113K 0.01%
+3,000
New +$94.4K
KFRC icon
194
Kforce
KFRC
$1.04B
$113K 0.01%
3,520
-4,560
-56% -$146K
BHVN
195
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$108K 0.01%
1,660
+520
+46% +$34.1K
FATE icon
196
Fate Therapeutics
FATE
$322M
$103K 0.01%
+2,580
New +$90.1K
PJT icon
197
PJT Partners
PJT
$4.33B
$101K 0.01%
+1,660
New +$93.3K
PTCT icon
198
PTC Therapeutics
PTCT
$6.23B
$101K 0.01%
2,170
– –
KYNB
199
Kyntra Bio
KYNB
$28.2M
$98K 0.01%
95
– –
GNMK
200
DELISTED
GenMark Diagnostics, Inc
GNMK
$97K 0.01%
+6,830
New +$104K
6 7
8
9 10

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Smith Group Asset Management held 350 positions worth $1.91B, up 5.5% from $1.81B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Smith Group Asset Management withdrew a net $61.7M in Q3 2020, closing 44 positions and reducing 147 holdings. Its most notable exit was Oracle, an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Smith Group Asset Management opened a new position in Thermo Fisher Scientific worth $13.7M.

  • Smith Group Asset Management's largest Q3 2020 buy was Thermo Fisher Scientific: 30,920 shares worth $13.7M.
  • Smith Group Asset Management added most to Lowe's Companies in Q3 2020, an estimated $21.7M increase.
  • Smith Group Asset Management's biggest Q3 2020 reduction was Bristol-Myers Squibb, cutting an estimated $14.5M.
  • Smith Group Asset Management fully exited Oracle in Q3 2020, selling an estimated $30.3M.
  • Smith Group Asset Management's ten largest holdings make up 41% of its $1.91B portfolio in Q3 2020.
  • Smith Group Asset Management opened 52 new positions and closed 44 in Q3 2020.
  • Smith Group Asset Management's portfolio value rose 5.5% quarter-over-quarter to $1.91B.

Based on Smith Group Asset Management's 13F filing for Q3 2020, filed 4 Nov 2020.